NexGel Goodwill and Intangible Assets 2021-2024 | NXGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NexGel goodwill and intangible assets from 2021 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NexGel goodwill and intangible assets from 2021 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$233.1B
Intuitive Surgical (ISRG)	$171.3B
Alcon (ALC)	$47.7B
IQVIA Holdings (IQV)	$44.2B
IDEXX Laboratories (IDXX)	$42.1B
Edwards Lifesciences (EW)	$40.7B
DexCom (DXCM)	$27.8B
STERIS (STE)	$23.5B
SONOVA HOLDING (SONVY)	$20.8B
Waters (WAT)	$19.8B
Hologic (HOLX)	$19B
Sysmex ADR (SSMXY)	$12.3B
Fresenius Medical Care AG KGaA (FMS)	$12.2B
Teleflex (TFX)	$11.4B
Globus Medical (GMED)	$9.4B
Penumbra (PEN)	$7.6B
Glaukos (GKOS)	$6.7B
Masimo (MASI)	$6.1B
TransMedics (TMDX)	$5.2B
PROCEPT BioRobotics (PRCT)	$4.3B
Integer Holdings (ITGR)	$4.3B
Tandem Diabetes Care (TNDM)	$2.8B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.6B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.6B
Nihon Kohden (NHNKY)	$2.5B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.2B